• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASCENSIA DIABETES CARE US INC. CONTOUR NEXT; BLOOD GLUCOSE TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASCENSIA DIABETES CARE US INC. CONTOUR NEXT; BLOOD GLUCOSE TEST STRIPS Back to Search Results
Model Number 7311
Medical Device Problem Code High Readings (2459)
Health Effect - Clinical Code Loss of consciousness (2418)
Date of Event 01/06/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The patient/family was the initial reporter , so personal information was not entered.No information was captured in section as the customer's weight was not provided.
 
Event or Problem Description
An advocate called on behalf of the customer to report that they obtained blood glucose readings of 245 mg/dl at 11:26 a.M.On the contour next ez meter and 121 mg/dl at 11:28 a.M.On the contour next meter.There was no allegation of an adverse event.The customer was advised to return the device for evaluation.A replacement meter kit was sent to the customer.
 
Additional Manufacturer Narrative
The customer returned the suspected contour next ez meter and contour next test strips from lot # 0epeg04b for evaluation.There were only two strips remaining in the vial of the returned test strips.Therefore, the in-house contour next test strips from lot # 0epeg04b were also used for testing.The suspected contour next meter was not returned for evaluation.Therefore, an in-house contour next meter was tested with a returned test strip and in-house test strips using a blood sample, which gave a satisfactory performance.Additionally, the returned meter was tested with a returned test strip and in-house test strips using a blood sample, which gave a satisfactory performance.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONTOUR NEXT
Common Device Name
BLOOD GLUCOSE TEST STRIPS
Manufacturer (Section D)
ASCENSIA DIABETES CARE US INC.
100 summit lake drive
valhalla NY 10595
Manufacturer (Section G)
PHC CORPORATION (REGISTRATION NUMBER: 1000134386)
2131-1 minamigata
toon ehime, 791-0 395
JA   791-0395
Manufacturer Contact
shweta gulati
100 summit lake drive
valhalla, NY 10595
9142361830
MDR Report Key11235585
Report Number1810909-2021-00053
Device Sequence Number4279542
Product Code NBW
UDI-Device Identifier10301937311502
UDI-Public10301937311502
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K111268
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Other
Remedial Action Replace
Type of Report Initial,Followup
Report Date (Section B) 01/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date05/31/2022
Device Model Number7311
Device Catalogue Number7311
Device Lot Number0EPEG04B
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/06/2022
Is the Reporter a Health Professional? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 01/08/2021
Supplement Date Received by Manufacturer01/06/2022
Initial Report FDA Received Date01/27/2021
Supplement Report FDA Received Date01/12/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/01/2020
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
Patient Sequence Number1
Patient Age12 YR
Patient SexFemale
-
-